Main Street Group
IONS icon

Main Street Group’s Ionis Pharmaceuticals IONS Stock Holding History

Main Street Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.46K Hold
100
– – ﹤0.01% 672
2026
Q2 		$7.93K Hold
100
– – ﹤0.01% 589
2026
Q1 		$7.51K Buy
+100
New +$7.89K ﹤0.01% 578

Other funds holding IONS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Tweedy, Browne Co
Tweedy, Browne Co Stamford, Connecticut $1.23B AUM 16.54% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return

Main Street Group's IONS Position: Q3 2026 in Review

Main Street Group held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 100 shares worth $4.46K. The position accounts for ﹤0.01% of the portfolio, ranked #672.

Main Street Group first reported a position in IONS in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.93K in Q2 2026. 194 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Main Street Group held 100 shares of Ionis Pharmaceuticals worth $4.46K as of Q3 2026.
  • Main Street Group left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Main Street Group's portfolio in Q3 2026, its #672 holding.
  • Main Street Group first reported a position in Ionis Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Main Street Group's Ionis Pharmaceuticals position peaked at $7.93K in Q2 2026.
  • 194 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Main Street Group's 13F filing for Q3 2026, filed 28 Oct 2026.